21 results for author:"Nilbert M." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Thelin M.A., Svensson K.J., Shi X., Bagher M., Axelsson J., Isinger-Ekstrand A., van Kuppevelt T.H., Johansson J., Nilbert M., Zaia J. et al. Cancer Res. 72:1943-1952(2012) · Mapped (3) |
| Ezrin expression in rectal cancer predicts time to development of local recurrence. Jorgren F., Nilbert M., Rambech E., Bendahl P.O., Lindmark G. Int J Colorectal Dis 27:893-899(2012) · Mapped (12) |
| Challenges in the identification of MSH6-associated colorectal cancer: rectal location, less typical histology, and a subset with retained mismatch repair function. Klarskov L., Holck S., Bernstein I., Okkels H., Rambech E., Baldetorp B., Nilbert M. Am. J. Surg. Pathol. 35:1391-1399(2011) · Mapped (6) |
| Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis. Rohlin A., Engwall Y., Fritzell K., Goransson K., Bergsten A., Einbeigi Z., Nilbert M., Karlsson P., Bjork J., Nordling M. Oncogene 30:4977-4989(2011) · Mapped (10) |
| Role for genetic anticipation in Lynch syndrome. Nilbert M., Timshel S., Bernstein I., Larsen K. J. Clin. Oncol. 27:360-364(2009) · Mapped (48) |
| Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72. Nilbert M., Kristoffersson U., Ericsson M., Johannsson O., Rambech E., Mangell P. BMC Med. Genet. 9:101-101(2008) · Mapped (10) |
| Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population. Nilbert M., Wikman F.P., Hansen T.V., Krarup H.B., Orntoft T.F., Nielsen F.C., Sunde L., Gerdes A.M., Cruger D., Timshel S. et al. Fam. Cancer 8:75-83(2009) · Mapped (48) |
| Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Magnusson S., Borg A., Kristoffersson U., Nilbert M., Wiebe T., Olsson H. Fam. Cancer 7:331-337(2008) · Mapped (66) |
| A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. Clendenning M., Senter L., Hampel H., Robinson K.L., Sun S., Buchanan D., Walsh M.D., Nilbert M., Green J., Potter J. et al. J. Med. Genet. 45:340-345(2008) · UniProtKB (1) · Mapped (3) |
| Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K., Liu T., Vandrovcova J., Halvarsson B., Clendenning M., Frebourg T., Papadopoulos N., Kinzler K.W., Vogelstein B., Peltomaki P. et al. J. Natl. Cancer Inst. 99:291-299(2007) · Mapped (55) |
| CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum. Isinger A., Bhat M., Borg A., Nilbert M. BMC Cancer 6:64-64(2006) · Mapped (9) |
| Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Fernebro J., Francis P., Eden P., Borg A., Panagopoulos I., Mertens F., Vallon-Christersson J., Akerman M., Rydholm A., Bauer H.C. et al. Int. J. Cancer 118:1165-1172(2006) · Mapped (15) |
| The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Charbonnier F., Baert-Desurmont S., Liang P., Di Fiore F., Martin C., Frerot S., Olschwang S., Wang Q., Buisine M.P., Gilbert B. et al. Hum. Mutat. 26:255-261(2005) · Mapped (12) |
| One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Malander S., Ridderheim M., Masbaeck A., Loman N., Kristoffersson U., Olsson H., Nilbert M., Borg A. Eur. J. Cancer 40:422-428(2004) · UniProtKB (2) · Mapped (17) |
| Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Planck M., Ericson K., Piotrowska Z., Halvarsson B., Rambech E., Nilbert M. Cancer 97:1551-1557(2003) · Mapped (42) |
| Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Engellau J., Akerman M., Anderson H., Domanski H.A., Rambech E., Alvegard T.A., Nilbert M. Appl. Immunohistochem. Mol. Morphol. 9:358-363(2001) · Mapped (5) |
| A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain. Koul A., Nilbert M., Borg A. Genes Chromosomes Cancer 24:207-212(1999) · Mapped (3) |
| Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Panagopoulos I., Mandahl N., Ron D., Hoglund M., Nilbert M., Mertens F., Mitelman F., Aman P. Cancer Res. 54:6500-6503(1994) · UniProtKB (1) |
| Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Kinzler K.W., Nilbert M.C., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hamilton S.R., Hedge P., Markham A. et al. |
| Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. et al. Science 253:665-669(1991) · UniProtKB (3) |
| Identification of FAP locus genes from chromosome 5q21. Kinzler K.W., Nilbert M.C., Su L.-K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D. et al. Science 253:661-665(1991) · UniProtKB (3) |